Non-obese non-alcoholic fatty liver disease and the risk of chronic kidney disease: a systematic review and meta-analysis
2024

Non-obese NAFLD and Chronic Kidney Disease Risk

Sample size: 127874 publication 10 minutes Evidence: moderate

Author Information

Author(s): You Yixian, Pei Xiong, Jiang Wei, Zeng Qingmin, Bai Lang, Zhou Taoyou, Lv Xiaoju, Tang Hong, Wu Dongbo

Primary Institution: Center of Infectious Diseases, West China Hospital, Sichuan University, Chengdu, China

Hypothesis

Is there a difference in the risk of chronic kidney disease (CKD) between non-obese and obese patients with non-alcoholic fatty liver disease (NAFLD)?

Conclusion

Non-obese NAFLD patients have the same risk of chronic kidney disease as obese NAFLD patients.

Supporting Evidence

  • Non-obese NAFLD patients had a CKD incidence of 3.74%.
  • Obese NAFLD patients had a CKD incidence of 3.64%.
  • Subgroup analyses showed no significant differences in CKD risk based on BMI cut-offs.

Takeaway

This study found that being non-obese with fatty liver disease doesn't mean you're at a higher risk for kidney problems compared to those who are obese.

Methodology

A systematic review and meta-analysis of 15 studies comparing CKD incidence in non-obese and obese NAFLD patients.

Potential Biases

Moderate risk of bias in included studies.

Limitations

Heterogeneity in study designs and potential confounding factors not fully adjusted for.

Participant Demographics

Studies included both Asian and non-Asian populations, with a mix of genders and ages over 18.

Statistical Information

P-Value

0.92

Confidence Interval

[0.72–1.19]

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.7717/peerj.18459

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication